🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

4 recruiting trials

for Advanced/recurrent Endometrial Cancer and Platinum-resistant Ovarian Cancer

A Study to Evaluate SSGJ-707 in Advanced Gynecologic Cancer Patients NCT06522828Phase 21 site📍 Chongqing Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. · Tests: SSGJ-707, carboplatin, paclitaxel A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors NCT06515613Phase 115 sites📍 Little Rock📍 Beverly Hills📍 Denver Context Therapeutics Inc. · Tests: CTIM-76 Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors NCT07444814Phase 112 sites📍 Little Rock📍 Los Angeles📍 Peoria Whitehawk Therapeutics, Inc. · Tests: HWK-007 A Phase 1 Study to Evaluate OPB-201 in Recurrent Endometrial and Platinum-resistant Ovarian Cancer. NCT07664735Phase 15 sites📍 San Francisco📍 Atlanta📍 Detroit Outpace Bio, Inc. · Tests: OPB-201
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy